Terumo Corp. (OTCMKTS:TRUMY) Sees Significant Decrease in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totaling 47,370 shares, a decline of 74.5% from the June 15th total of 185,946 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 268,986 shares, the short-interest ratio is currently 0.2 days.

Terumo Trading Down 1.0%

Shares of OTCMKTS TRUMY traded down $0.14 during midday trading on Friday, hitting $13.59. 117,827 shares of the company traded hands, compared to its average volume of 120,095. Terumo has a 12-month low of $12.08 and a 12-month high of $19.60. The firm has a market cap of $20.05 billion, a P/E ratio of 22.28 and a beta of 0.68. The stock has a 50-day moving average price of $13.81 and a 200 day moving average price of $13.61. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Friday, May 15th. The company reported $0.11 EPS for the quarter, hitting the consensus estimate of $0.11. The business had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. As a group, analysts expect that Terumo will post 0.7 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Terumo presently has a consensus rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.